Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter

Date: 07/01/2021

Product type: Drugs, Potential Foreign Material

Company Announcement Date: June 30, 2021
FDA Publish Date: July 01, 2021
Product Type: Drugs
Reason for Announcement: Presence of particulate matter
Company Name: Teva Pharmaceuticals
Brand Name: Teva
Product Description: Topotecan Injection 4 mg/4 mL (1 mg/mL)

US-FDA Link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-initiates-voluntary-nationwide-recall-one-lot-topotecan-injection-4-mg4-ml-1-mgml-due-presence